Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

NKGen Biotech Presents Phase 1/2a Data On Troculeucel In Alzheimer's Disease At CTAD Conference, Showing Biomarker Reductions And Cognitive Improvement; Highest Dose Demonstrates Safety With Potential To Delay Dementia

Author: Benzinga Newsdesk | October 29, 2024 08:07am

Posted In: NKGN